Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2019 | 3 |
2020 | 2 |
2021 | 1 |
2022 | 1 |
2023 | 2 |
2024 | 1 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Drug Stability and Minimized Acid-/Drug-Catalyzed Phospholipid Degradation in Liposomal Irinotecan.
J Pharm Sci. 2023 Feb;112(2):416-434. doi: 10.1016/j.xphs.2022.11.025. Epub 2022 Dec 1.
J Pharm Sci. 2023.
PMID: 36462709
Free article.
Unleashing the Potential: Designing Antibody-Targeted Lipid Nanoparticles for Industrial Applications with CMC Considerations and Clinical Outlook.
Wang S, Wang H, Drabek A, Smith WS, Liang F, Huang ZR.
Wang S, et al. Among authors: huang zr.
Mol Pharm. 2024 Jan 1;21(1):4-17. doi: 10.1021/acs.molpharmaceut.3c00735. Epub 2023 Dec 20.
Mol Pharm. 2024.
PMID: 38117251
Review.
Item in Clipboard
Antitumour activity and tolerability of an EphA2-targeted nanotherapeutic in multiple mouse models.
Kamoun WS, Kirpotin DB, Huang ZR, Tipparaju SK, Noble CO, Hayes ME, Luus L, Koshkaryev A, Kim J, Olivier K, Kornaga T, Oyama S, Askoxylakis V, Pien C, Kuesters G, Dumont N, Lugovskoy AA, Schihl SA, Wilton JH, Geddie ML, Suchy J, Grabow S, Kohli N, Reynolds CP, Blaydes R, Zhou Y, Sawyer AJ, Marks JD, Drummond DC.
Kamoun WS, et al. Among authors: huang zr.
Nat Biomed Eng. 2019 Apr;3(4):264-280. doi: 10.1038/s41551-019-0385-4. Epub 2019 Apr 5.
Nat Biomed Eng. 2019.
PMID: 30952988
Item in Clipboard
Targeting EphA2 in Bladder Cancer Using a Novel Antibody-Directed Nanotherapeutic.
Kamoun W, Swindell E, Pien C, Luus L, Cain J, Pham M, Kandela I, Huang ZR, Tipparaju SK, Koshkaryev A, Askoxylakis V, Kirpotin DB, Bloom T, Mino-Kenudson M, Marks JD, Zalutskaya A, Bshara W, Morrison C, Drummond DC.
Kamoun W, et al. Among authors: huang zr.
Pharmaceutics. 2020 Oct 20;12(10):996. doi: 10.3390/pharmaceutics12100996.
Pharmaceutics. 2020.
PMID: 33092175
Free PMC article.
Item in Clipboard
Liposomal encapsulation of trans-crocetin enhances oxygenation in patients with COVID-19-related ARDS receiving mechanical ventilation.
Mertes PM, Collange O, Coliat P, Banerjee M, Diringer MC, Roche A, Delabranche X, Chaban V, Voegelin M, Bernard A, Sartori V, Laurent N, Velten M, Dhindsa N, Defuria J, Kim G, Xu ZH, Theodorou M, Huang ZR, Khalifa K, Geng B, Niyikiza C, Moyo V, Gizzi P, Villa P, Detappe A, Pivot X.
Mertes PM, et al. Among authors: huang zr.
J Control Release. 2021 Aug 10;336:252-261. doi: 10.1016/j.jconrel.2021.06.033. Epub 2021 Jun 24.
J Control Release. 2021.
PMID: 34175365
Free PMC article.
Item in Clipboard
Formulation optimization of an ephrin A2 targeted immunoliposome encapsulating reversibly modified taxane prodrugs.
Huang ZR, Tipparaju SK, Kirpotin DB, Pien C, Kornaga T, Noble CO, Koshkaryev A, Tran J, Kamoun WS, Drummond DC.
Huang ZR, et al.
J Control Release. 2019 Sep 28;310:47-57. doi: 10.1016/j.jconrel.2019.08.006. Epub 2019 Aug 7.
J Control Release. 2019.
PMID: 31400383
Item in Clipboard
Synergy between EphA2-ILs-DTXp, a Novel EphA2-Targeted Nanoliposomal Taxane, and PD-1 Inhibitors in Preclinical Tumor Models.
Kamoun WS, Dugast AS, Suchy JJ, Grabow S, Fulton RB, Sampson JF, Luus L, Santiago M, Koshkaryev A, Sun G, Askoxylakis V, Tam E, Huang ZR, Drummond DC, Sawyer AJ.
Kamoun WS, et al. Among authors: huang zr.
Mol Cancer Ther. 2020 Jan;19(1):270-281. doi: 10.1158/1535-7163.MCT-19-0414. Epub 2019 Oct 9.
Mol Cancer Ther. 2020.
PMID: 31597714
Item in Clipboard
Cite
Cite